agencies congressional-research-service 
Olartemoure Blog
AUGUST 19, 2022
Product, service and process innovation . Additionally, the United States approved the Science and Technology Act, securing USD 179 billion in investments over five years to encourage and promote research and development. . Innovation culture . Qualified human talent . Relationship with the STI ecosystem .
LexBlog IP
APRIL 29, 2022
The surprise portion of the meeting was brought to you by the Telemarketing Sales Rule (TSR), which is a broad rule that regulates what telemarketers can and cannot do with respect to contacting consumers and also sets payment restrictions for the sale of goods and services made through telemarketing calls.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LexBlog IP
OCTOBER 20, 2022
EPA , in which the Supreme Court ruled that regulatory agencies must have “clear congressional authorization” to make rules pertaining to “major questions” that are of great political or economic significance. There was less discussion about West Virginia v. It will hold the comment period open another month.
Technology & Marketing Law Blog
JUNE 27, 2022
In order to determine who is a child, websites and apps will have to authenticate the age of ALL consumers before they can use the service. The bill applies to a “business that provides an online service, product, or feature likely to be accessed by a child.” NO ONE WANTS THIS. Bye bye casual browsing. What the Bill Says.
LexBlog IP
NOVEMBER 9, 2021
However, cybersecurity service and software providers, forensics firms, IT infrastructure manufacturers and those engaged in vulnerability testing, research, bug-bounty programs and other white-hat activities may take a different view. BIS asserts these new export controls are narrow in scope and will have minimal impact.
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
The continued slow pace of approvals is potentially the result of the COVID-19 pandemic and related delays in clinical trials and facility inspections by FDA, as well as a re-prioritization and shifting of agency resources towards COVID-19 vaccines and treatments. Biosimilar Regulatory Updates. Tackling Biologic Drug Pricing.
Technology & Marketing Law Blog
MAY 7, 2022
The court curtly responds that they’ve been applied in a wide variety of contexts, and “a scant minute of online research makes this abundantly clear.”]. Government Jawboning Doesn’t Turn Internet Services into State Actors–Doe v. Congressional Jawboning of Internet Services Isn’t Actionable–AAPS v.
Expert insights. Personalized for you.
98 
Let's personalize your content